Australia markets open in 2 hours 46 minutes

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
60.10-0.59 (-0.97%)
At close: 04:00PM EDT
60.30 +0.20 (+0.33%)
After hours: 04:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.97B
Enterprise value 6.21B
Trailing P/E 32.49
Forward P/E 18.12
PEG ratio (5-yr expected) 1.51
Price/sales (ttm)3.27
Price/book (mrq)3.08
Enterprise value/revenue 3.98
Enterprise value/EBITDA 17.44

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3-13.36%
S&P500 52-week change 3-5.12%
52-week high 376.70
52-week low 355.16
50-day moving average 362.41
200-day moving average 366.77

Share statistics

Avg vol (3-month) 3486.94k
Avg vol (10-day) 3348.56k
Shares outstanding 583.14M
Implied shares outstanding 6N/A
Float 872.11M
% held by insiders 113.08%
% held by institutions 192.39%
Shares short (28 Apr 2022) 44.48M
Short ratio (28 Apr 2022) 49.56
Short % of float (28 Apr 2022) 47.18%
Short % of shares outstanding (28 Apr 2022) 45.39%
Shares short (prior month 30 Mar 2022) 44.55M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 303 Jan 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 10.04%
Operating margin (ttm)18.40%

Management effectiveness

Return on assets (ttm)4.84%
Return on equity (ttm)9.96%

Income statement

Revenue (ttm)1.56B
Revenue per share (ttm)18.45
Quarterly revenue growth (yoy)4.60%
Gross profit (ttm)976.97M
EBITDA 407.22M
Net income avi to common (ttm)156.58M
Diluted EPS (ttm)1.84
Quarterly earnings growth (yoy)-27.50%

Balance sheet

Total cash (mrq)407.09M
Total cash per share (mrq)4.9
Total debt (mrq)1.66B
Total debt/equity (mrq)102.93
Current ratio (mrq)3.38
Book value per share (mrq)19.43

Cash flow statement

Operating cash flow (ttm)287.69M
Levered free cash flow (ttm)256.13M